Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Candida is a leading cause of healthcare-associated bloodstream infections in the United States. Infants and children have unique risk factors for candidemia, and the Candida species distribution in this group is different that among adults; however, candidemia epidemiology in this population has not been described recently. METHODS: We conducted active population-based candidemia surveillance in 4 US metropolitan areas between 2009 and 2015. We calculated incidences among neonates (0-30 days old), infants (0-364 days old), and noninfant children (1-19 years old), documented their clinical features and antifungal drug resistance. RESULTS: We identified 307 pediatric candidemia cases. Incidence trends varied according to site, but overall, the incidence in neonates decreased from 31.5 cases/100000 births in 2009 to 10.7 to 11.8 cases/100000 births between 2012 and 2015, the incidence in infants decreased from 52.1 cases/100000 in 2009 to 15.7 to 17.5 between 2012 and 2015, and the incidence in noninfant children decreased steadily from 1.8 cases/100000 in 2009 to 0.8 in 2014. Common underlying conditions were prematurity in neonates (78%), surgery in nonneonate infants (38%), and malignancy in noninfant children (28%). Most neonate cases were caused by C albicans (67%), whereas non-C. albicans species accounted for 60% of cases in nonneonate infants and noninfant children. Fluconazole and echinocandin resistance rates were low overall. Thirty-day crude mortality was 13%. CONCLUSIONS: The incidence of candidemia among neonates and infants declined after 2009 but remained stable from 2012 to 2015. Antifungal drug resistance is uncommon. Reasons for the lack of recent declines in neonatal and infant candidemia deserve further exploration. In this article, we describe the epidemiology of candidemia in children in the United States and on the basis of data collected as part of US Centers for Disease Control and Prevention active population-based surveillance. Trends in incidence, clinical characteristics, species distribution, and resistance rates are presented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The incidence of candidemia started to decrease in the mid-1990s through the mid-2000s among low birthweight newborns, in part because of recommendations for fluconazole prophylaxis in certain settings (25–27).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [26]
In the citing paper
“This contrasts with data from the early 1990s, when infants had the highest incidence (6), followed by substantial decreases by the late 2000s (26,28).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [26]
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · cited 2×
“The 2009 and 2016 Infectious Diseases Society of America clinical practice guidelines for the management of candidiasis recommend antifungal prophylaxis in neonates who weigh less than 1000 g and are in a neonatal ICU (NICU) with a high candidemia rate [8, 9].”
BackgroundMultistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Self-citationPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758
Almirante, B., Rodríguez, D., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sanchez, F., Ayats, J., Gimenez, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1829-1835.2005 · Cited by 566
Colombo, A. L., Nucci, M., Park, B. J., Nouér, S. A., Arthington-Skaggs, B., da Matta, D. A., Warnock, D., & Morgan, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00773-06 · Cited by 526
Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Donowitz, L. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010494 · Cited by 523
Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000
Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380637 · Cited by 478
Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants
Kaufman, D., & Fairchild, K. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.3.638-680.2004 · Cited by 435 · cited 1×
“Candida species are distributed differentially according to age, especially in neonates, in whom C albicans and C parapsilosis predominate [6],”
BackgroundVital signs: improving antibiotic use among hospitalized patients.
Fridkin, S. K., Baggs, J. M., Fagan, R. P., Magill, S. S., Pollack, L. A., Malpiedi, P. J., Slayton, R. B., Khader, K., Rubin, M. A., Jones, M., et al. (2014) · PubMed Central · Cited by 401
Risk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study
Wey, S. B. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100145030 · Cited by 369 · cited 2×
“Having received broad-spectrum antibiotics is a well-known risk factor for candidemia [5].”
BackgroundCleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis697 · Cited by 366 · cited 1×
“Recent reports documented a decline in candidemia rates among infants aged <1 year [2, 10].”
BackgroundSelf-citationA Multicenter, Randomized Trial of Prophylactic Fluconazole in Preterm Neonates
Manzoni, P., Stolfi, I., Pugni, L., Decembrino, L., Magnani, C., Vetrano, G., Tridapalli, E., Corona, G., Giovannozzi, C., Farina, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065733 · Cited by 356
KOSSOFF, E. H., BUESCHER, E. S., & KARLOWICZ, M. G. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199806000-00014 · Cited by 330
Schulman, J., Stricof, R., Stevens, T. P., Horgan, M., Gase, K., Holzman, I. R., Koppel, R. I., Nafday, S., Gibbs, K., Angert, R., et al. (2011) · Pediatrics · doi:10.1542/peds.2010-2873 · Cited by 316
Cleveland, A. A., Harrison, L. H., Farley, M. M., Hollick, R., Stein, B., Chiller, T. M., Lockhart, S. R., & Park, B. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120452 · Cited by 304 · cited 11×
“Candida is a leading cause of healthcare-associated bloodstream infections in the United States.”
BackgroundResultInfluentialSelf-citationFridkin, S. K., Kaufman, D., Edwards, J. R., Shetty, S., Horan, T., & Hospitals, T. N. N. I. S. S. (2006) · Pediatrics · doi:10.1542/peds.2005-1996 · Cited by 284 · cited 1×
“Our data are consistent with those published using the CDC National Healthcare Safety Network (NHSN) and its predecessor, the National Nosocomial Infections Surveillance System (NNIS), which revealed a decline in neonatal candidemia incidence rates between 1999 and 2009 [18, 19].”
ResultEmergence of Candida parapsilosis as the Predominant Species Causing Candidemia in Children
Levy, I., Rubin, L. G., Vasishtha, S., Tucci, V., & Sood, S. K. (1998) · Clinical Infectious Diseases · doi:10.1086/520277 · Cited by 210
Candida parapsilosis Is a Significant Neonatal Pathogen: A Systematic Review and Meta-analysis
Pammi, M., Holland, L., Butler, G., Gacser, A., & Bliss, J. M. (2013) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182863a1c · Cited by 206 · cited 1×
“colonization present on the hands of healthcare workers [47].”
BackgroundBlyth, C. C., Chen, S. C. A., Slavin, M. A., Serena, C., Nguyen, Q., Marriott, D., Ellis, D., Meyer, W., Sorrell, T. C., & Study, O. B. O. M. O. T. A. C. (2009) · Pediatrics · doi:10.1542/peds.2008-2055 · Cited by 206
Vallabhaneni, S., Cleveland, A. A., Farley, M. M., Harrison, L. H., Schaffner, W., Beldavs, Z. G., Derado, G., Pham, C. D., Lockhart, S. R., & Smith, R. M. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv163 · Cited by 187
Self-citationSarvikivi, E., Lyytikäinen, O., Soll, D. R., Pujol, C., Pfaller, M. A., Richardson, M., Koukila-Kähkölä, P., Luukkainen, P., & Saxén, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2729-2735.2005 · Cited by 178
Candidemia in Norway (1991 to 2003): Results from a Nationwide Study
Sandven, P., Bevanger, L., Digranes, A., Haukland, H. H., Mannsåker, T., Gaustad, P., & the Norwegian Yeast Study Group (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00029-06 · Cited by 173
Steinbach, W. J., Roilides, E., Berman, D., Hoffman, J. A., Groll, A. H., Bin-Hussain, I., Palazzi, D. L., Castagnola, E., Halasa, N., Velegraki, A., et al. (2012) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182737427 · Cited by 171
Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Grossman, L. B. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.03.036 · Cited by 164
Is Bloodstream Infection Preventable Among Premature Infants? A Tale of Two Cities
Aly, H. Z., HERSON, V. C., Duncan, A., Herr, J., Bender, J., Patel, K. M., & El-Mohandes, A. A. E. (2005) · PEDIATRICS · doi:10.1542/peds.2004-1785 · Cited by 155
Healy, C. M., Campbell, J. R., Zaccaria, E., & Baker, C. J. (2008) · Pediatrics · doi:10.1542/peds.2007-1130 · Cited by 153
Bizzarro, M. J., Sabo, B., Noonan, M., Bonfiglio, M.-P., Northrup, V., Diefenbach, K., & Central Venous Catheter Initiative Committee (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/650448 · Cited by 138
Hope, W. W., Morton, A., & Eisen, D. P. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1131 · Cited by 130
Zaoutis, T. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.487796 · Cited by 102 · cited 1×
“most common risk factors in neonates, and hematologic malignancy and neutropenia are frequent candidemia risk factors in noninfant children [3, 4].”
BackgroundAsmundsdottir, L. R., Erlendsdottir, H., & Gottfredsson, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02566-12 · Cited by 100
Candidemia in Neonatal Intensive Care Units: Barcelona, Spain
Rodriguez, D., Almirante, B., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Sanchez, F., Gene, A., Xercavins, M., Fontanals, D., Rodriguez-Tudela, J. L., et al. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000202127.43695.06 · Cited by 99
Wirtschafter, D. D., Pettit, J., Kurtin, P. S., Dalsey, M., Chance, K., Morrow, H. W., Seid, M., Byczkowski, T. L., Huber, T., Milstein, J. M., et al. (2009) · Journal of Perinatology · doi:10.1038/jp.2009.172 · Cited by 94
Manzoni, P., Leonessa, M., Galletto, P., Latino, M. A., Arisio, R., Maule, M., Agriesti, G., Gastaldo, L., Gallo, E., Mostert, M., et al. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318170bb0c · Cited by 93
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., Koivula, I., Lumio, J., Kotilainen, P., Syrjälä, H., & Ruutu, P. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-312 · Cited by 93
Epidemiology of Candidemia at a Children's Hospital, 2002 to 2006
Neu, N., Malik, M., Lunding, A., Whittier, S., Alba, L., Kubin, C., & Saiman, L. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a0d78d · Cited by 92
Trends in Candida Central Line-Associated Bloodstream Infections Among NICUs, 1999–2009
Chitnis, A. S., Magill, S. S., Edwards, J. R., Chiller, T. M., Fridkin, S. K., & Lessa, F. C. (2012) · Pediatrics · doi:10.1542/peds.2011-3620 · Cited by 78 · cited 1×
“Our data are consistent with those published using the CDC National Healthcare Safety Network (NHSN) and its predecessor, the National Nosocomial Infections Surveillance System (NNIS), which revealed a decline in neonatal candidemia incidence rates between 1999 and 2009 [18, 19].”
ResultSelf-citationLehrnbecher, T., Ethier, M., Zaoutis, T. E., Creutzig, U., Gamis, A. S., Reinhardt, D., Aplenc, R., & Sung, L. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07844.x · Cited by 77 · cited 1×
“Fluconazole is the most widely used agent [51], but as more safety data become available, echinocandins can be used also.”
BackgroundAydemir, C., Oguz, S. S., Dizdar, E. A., Akar, M., Sarikabadayi, Y. U., Saygan, S., Erdeve, O., & Dilmen, U. (2011) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/adc.2009.178996 · Cited by 74 · cited 1×
“trials that revealed a benefit from antifungal prophylaxis [26, 27].”
BackgroundEffect of fluconazole consumption on long-term trends in candidal ecology
Blot, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl241 · Cited by 72
Antifungal prophylaxis in pediatric hematology/oncology: New choices & new data
Dvorak, C. C., Fisher, B. T., Sung, L., Steinbach, W. J., Nieder, M. L., Alexander, S. W., & Zaoutis, T. E. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23415 · Cited by 71 · cited 3×
“Previous studies documented the 1-year incidence of invasive fungal diseases (IFDs) among pediatric oncology patients and hematopoietic cell transplant (HCT) recipients to be as high as 13% to 20% and the mortality rate to be 58% to 83% [50].”
BackgroundInfluentialAntifungal Prophylaxis to Prevent Neonatal Candidiasis: A Survey of Perinatal Physician Practices
Burwell, L. A., Kaufman, D., Blakely, J., Stoll, B. J., & Fridkin, S. K. (2006) · Pediatrics · doi:10.1542/peds.2006-0446 · Cited by 69
Strategies to Prevent Invasive Candidal Infection in Extremely Preterm Infants
Kaufman, D. A., & Manzoni, P. (2010) · Clinics in Perinatology · doi:10.1016/j.clp.2010.06.003 · Cited by 65 · cited 1×
“Neonatal and Pediatric Candidemia • JPIDS 2018:7 (September) • e79 antifungal treatment, and antifungal prophylaxis [7].”
BackgroundCandida Speciation, Antifungal Treatment and Adverse Events in Pediatric Invasive Candidiasis
Palazzi, D. L., Arrieta, A. C., Castagnola, E., Halasa, N., Hubbard, S., Brozovich, A., Fisher, B. T., & Steinbach, W. J. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000431 · Cited by 34 · cited 1×
“In our study, C parapsilosis remained the most common NAC species among infants and children, which is a finding that has been well documented already [3, 43, 45, 46].”
Deak, E., Etienne, K. A., Lockhart, S. R., Gade, L., Chiller, T., & Balajee, S. A. (2010) · Canadian Journal of Microbiology · doi:10.1139/w10-003 · Cited by 29 · cited 2×
“Isolate Identification and Antifungal-Susceptibility Testing At the CDC fungal reference laboratory, Candida species were confirmed using a Luminex assay (Luminex Corporation, Austin, Texas) or DNA sequencing of the D1/D2 subunit of the 28S ribosomal DNA [15] until 2014; matrix-assisted laser desorption–ionization tim…”
MethodSelf-citationCrawford, S. B., Joshi, N., Boulet, S. L., Bailey, M. A., Hood, M., Manning, S. E., McKane, P., Kirby, R. S., Kissin, D. M., Jamieson, D. J., et al. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002031 · Cited by 25
Research works printed but not linked: 5
- CLSI document M27-A3, 2008, Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard–third edition
- M27-S4, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; 4th Informational Supplement
- National Center for Health Statistics, All-county birth data (2009–2015) as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program
- Blyth, 2009, Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients, Pediatrics, 123, 1360, 10.1542/peds.2008-2055 · DOI · Paper page
- Fanfair RN AA , FarleyM, et al Racial disparities in candidemia: results from population-based surveillance in the United States, 2008–2010. International Conference on Antimicrobials and Chemotherapeutics (ICAAC). Chicago, September 17–20, 2011.
Cited by
Lass-Flörl, C., Kanj, S. S., Govender, N. P., Thompson, G. R., Ostrosky- Zeichner, L., & Govrins, M. A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00503-3 · Cited by 298
“In addition, during the past few years, the population at risk expanded due to COVID-19-related C andida infections 164 and the emergence of fungal break-through infections 165 .”
Toda, M., Williams, S. R., Berkow, E. L., Farley, M. M., Harrison, L. H., Bonner, L., Marceaux, K. M., Hollick, R., Zhang, A. Y., Schaffner, W., et al. (2019) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6808a1 · Cited by 198
Self-citationWarris, A., Pana, Z. D., Oletto, A., Lundin, R., Castagnola, E., Lehrnbecher, T., Groll, A. H., & Roilides, E. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002530 · Cited by 124
Recent Trends in the Epidemiology of Fungal Infections
Seagle, E. E., Williams, S., & Chiller, T. M. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.001 · Cited by 114
Self-citationParambath, S., Dao, A., Kim, H. Y., Zawahir, S., Alastruey‐Izquierdo, A., Tacconelli, E., Govender, N. P., Oladele, R. O., Colombo, A. L., Sorrell, T. C., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae045 · Cited by 109
“Benedict et al. 20 and Ryan et al. 54 also found that the overall incidence of candidaemia was decreasing over time in paediatric and adult populations.”
Background
Metadata
- Authors
- Benedict, K., Roy, M., Kabbani, S., Anderson, E. J., Farley, M. M., Harb, S., Harrison, L. H., Bonner, L., Wadu, V. L., Marceaux, K., Hollick, R., Beldavs, Z. G., Zhang, A. Y., Schaffner, W., Graber, C. R., Derado, G., Chiller, T. M., Lockhart, S. R., & Vallabhaneni, S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Emory University (US)
- Johns Hopkins University (US)
- Maryland Emerging Infections Program, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
- Acute and Communicable Disease Prevention, Oregon Health Authority, Portland
- Oregon Health Authority (US)
- Vanderbilt University (US)
- Corresponding author
- Vallabhaneni, Snigdha
- ORCID
- Venue
- Journal of the Pediatric Infectious Diseases Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-03-07
- Volume
- 7
- Issue
- 3
- Pages
- e78-e85
- ISSN
- 2048-7193 (ISSN-L)
- 2048-7207
- OpenAlex
- W2789278748
- Cited by
- 81
- References
- 49
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 15 · 2023: 7 · 2022: 8 · 2021: 16 · 2020: 9 · 2019: 5 · 2018: 3
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the Pediatric Infectious Diseases Society (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, neonatal candidemia, Candida albicans, non-albicans Candida, antifungal resistance, fluconazole resistance, echinocandin resistance, healthcare-associated bloodstream infections, preterm birth, mortality, risk factors, United States metropolitan areas, 2009 H1N1 influenza
- MeSH terms
- Adolescent, Antifungal Agents, Candida albicans, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Infant, Premature, Male, Population Surveillance, Prospective Studies, Risk Factors, United States, Fluconazole, Incidence, Drug Resistance, Fungal, Echinocandins, Young Adult, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.